Covered recipient · General Payments record
BETH L JOLLY
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$1,402.04
- Reported across 66 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $563.43 | 31 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $300.54 | 19 |
| Teva Pharmaceuticals USA, Inc. | $94.96 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $34.75 | 2 |
| Biogen, Inc. | $30.84 | 1 |
| Celgene Corporation | $29.99 | 2 |
| TG THERAPEUTICS, INC. | $29.46 | 1 |
| Genentech USA, Inc. | $24.16 | 1 |
| PFIZER INC. | $18.73 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (31)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820202023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.70 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104005514 | CMS |
| ABBVIE INC. | $18.76 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104005516 | CMS |
| ABBVIE INC. | $18.18 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104005518 | CMS |
| ABBVIE INC. | $14.44 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104005520 | CMS |
| ABBVIE INC. | $28.46 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104005522 | CMS |
| ABBVIE INC. | $18.78 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104005524 | CMS |
| ABBVIE INC. | $24.73 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104005526 | CMS |
| ABBVIE INC. | $3.01 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104005528 | CMS |
| ABBVIE INC. | $16.12 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104005530 | CMS |
| ABBVIE INC. | $9.83 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104005532 | CMS |
| ABBVIE INC. | $15.47 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104005534 | CMS |
| ABBVIE INC. | $8.49 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104005536 | CMS |
| ABBVIE INC. | $7.30 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104005538 | CMS |
| ABBVIE INC. | $4.89 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104005540 | CMS |
| ABBVIE INC. | $17.80 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104005542 | CMS |
| ABBVIE INC. | $9.25 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104005544 | CMS |
| ABBVIE INC. | $33.69 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104005546 | CMS |
| ABBVIE INC. | $25.36 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104005548 | CMS |
| ABBVIE INC. | $17.28 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104005550 | CMS |
| Biogen, Inc. | $30.84 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104843238 | CMS |
| Celgene Corporation | $13.72 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101121311 | CMS |
| Celgene Corporation | $16.27 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101121315 | CMS |
| Genentech USA, Inc. | $24.16 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132981482 | CMS |
| Novartis Pharmaceuticals Corporation | $18.80 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087096702 | CMS |
| Novartis Pharmaceuticals Corporation | $15.95 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087096750 | CMS |
| PFIZER INC. | $18.73 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131173785 | CMS |
| Teva Pharmaceuticals USA, Inc. | $32.48 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151726721 | CMS |
| Teva Pharmaceuticals USA, Inc. | $21.99 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151726763 | CMS |
| Teva Pharmaceuticals USA, Inc. | $20.69 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151726793 | CMS |
| Teva Pharmaceuticals USA, Inc. | $19.80 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151726891 | CMS |
| TG Therapeutics, Inc. | $29.46 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136891010 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.